What happened
D&D Pharmatech updated a previously disclosed supply contract with Pfizer Inc., now worth US$1.7M, about 58.79% of its recent annual revenue, running through Feb 2028.
For context, this single contract equals about 58.79% of the company's most recent annual revenue.
| Counterparty | Pfizer Inc. |
|---|---|
| Contract value | US$1.7M |
| vs. recent revenue | 58.79% |
| Through | Feb 2028 (from Apr 2026) |
| Filed | 2026-07-14, [Amended] Supply contract signed |
| Source | DART rcept 20260714900144 → open original filing |
Versions of this filing
- 2026-04-16Original
- 2026-07-14Amendment 1 (this page)
Source: DART. Information only, not investment advice.